2005
DOI: 10.1073/pnas.0507965102
|View full text |Cite
|
Sign up to set email alerts
|

The sodium pump and hypertension: A physiological role for the cardiac glycoside binding site of the Na,K-ATPase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
9
0
1

Year Published

2007
2007
2023
2023

Publication Types

Select...
5
2
2

Relationship

1
8

Authors

Journals

citations
Cited by 19 publications
(10 citation statements)
references
References 27 publications
0
9
0
1
Order By: Relevance
“…On the other hand, cardiac glycosides were present in our extract as previously reported by Edeoga et al (2005) in a Nigerian plant sample. Plant extracts containing cardiac glycosides have been used for their therapeutic effects (Kaplan, 2005) but could be a source of toxicity (Demiryurek and Demiryurek, 2005).…”
Section: Staphylococcus Aureusmentioning
confidence: 99%
“…On the other hand, cardiac glycosides were present in our extract as previously reported by Edeoga et al (2005) in a Nigerian plant sample. Plant extracts containing cardiac glycosides have been used for their therapeutic effects (Kaplan, 2005) but could be a source of toxicity (Demiryurek and Demiryurek, 2005).…”
Section: Staphylococcus Aureusmentioning
confidence: 99%
“…It is known that CTS are elevated during volume expansion. The cardiotonic steroid binding site of the Na-K-ATPase is believed to be the molecular target of the hypertensive effects of these compounds, and appears to play an important role in blood pressure regulation [125,126]. Our recent in vivo studies have demonstrated that elevated endogenous CTS and endocytosis of the Na/K-ATPase play an important role in renal adaptation to volume expansion.…”
Section: Physiological Implicationsmentioning
confidence: 99%
“…It is the target of cardiac glycosides, such as digitalis, and the catalytic a subunit contains the glycoside binding site as well as the conserved aspartate residue that undergoes cyclic phosphorylation and dephosphorylation events that drive the conformational transitions underlying the operation of this P-type ion pump. Its activity maintains the transmembrane electrochemical alkali cation gradients that are coupled to the flux of other ions by a host of exchangers and cotransporters and that are dissipated by ion channels in the propagation of action potentials [Kaplan, 2002[Kaplan, , 2005Jorgensen et al, 2003]. It was therefore surprising that a disease phenotype as subtle, intermittent, and localized as FHM should be linked to mutations in ATP1A2, encoding the a2 isoform of the major subunit of this mechanism [De Fusco et al, 2003;Kaunisto et al, 2004].…”
Section: Pathophysiology Of Fhmmentioning
confidence: 99%